Benedikt Migdal

Partner *

Dusseldorf

Benedikt advises on complex commercial and technology transactions and represents clients in patent and trade secret litigation.

Benedikt advises on structuring and negotiating the IP aspects of corporate transactions, including M&A, divestments and venture investments as well as of commercial transactions where intellectual property rights and know-how are key assets. His work encompasses, for example, IP licensing and technology transfer agreements, engineering services agreements, transition services agreements, R&D collaborations, and IP aspects of contracts throughout the life sciences sector.

Benedikt is also an experienced patent and trade secret litigator and has represented German and international clients from a range of industries in complex disputes, especially concerning patents and know-how in the fields of mobile telecommunication/connectivity and the life sciences.

Based on his extensive experience in both IP transactions and litigation, he deeply understands the full range of legal and economical issues that technology-driven companies are challenged with in context with IP. This also includes IP-related competition law issues, such as FRAND-requirements for licensing and enforcing standard essential patents as well as issues arising in connection with EU regulations concerning technology transfers.

    • Advising a U.S. life sciences company on the acquisition of a German med-tech company.
    • Advising a German life sciences company on multi-tier technology licences and know-how transfer agreements relating to radiopharmaceuticals in connection with the establishment of a joint venture with a Chinese company.
    • Advising a leading U.S. group of companies on the acquisition of a German manufacturer of industrial 3D printers and representing the new subsidiary in German patent litigation.
    • Advising a Swedish life sciences company on the acquisition of a German company focusing on precision dispensing technologies.
    • Advising an automotive company on a strategic partnership with an engineering services provider.
    • Advising and representing a leading pharma company in various patent and SPC infringement matters.
    • Advising and representing an automotive manufacturer in patent infringement disputes relating to (standard essential) connectivity patents.
    • Advising and representing an IP management and patent licensing company in various patent infringement litigations pertaining to standard essential patents.
    • Advising and representing a Danish life sciences company in preliminary injunction proceedings for trade secret infringement by a competitor.

Événements